<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03422016</url>
  </required_header>
  <id_info>
    <org_study_id>17PP33</org_study_id>
    <nct_id>NCT03422016</nct_id>
  </id_info>
  <brief_title>Electroretinogram in Autistic Spectrum Disorders</brief_title>
  <acronym>ERG in ASD</acronym>
  <official_title>The Incidence of Altered Light Responses in Children With Autistic Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Flinders University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swinburne University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Great Ormond Street Hospital for Children NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to find out the incidence of a reduced light adapted electroretinogram (ERG)
      b-wave amplitude in children with a diagnosis of Autism Spectrum Disorders (ASD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism Spectrum Disorder (ASD) is a neurodevelopmental condition which becomes apparent as
      children grow. Children with ASD are slow to develop language and have problems interacting
      socially with others. It is not clear why ASD occurs, but there is some evidence that the
      signals that tell the brain how to grow are altered which causes the brain to develop and
      function differently in people with ASD. Eyes develop from the same embryonic tissue as the
      brain. This means that the retina, which is the light sensitive layer at the back of the eye,
      shares the same signals as the brain. Investigators can listen to retinal signals outside the
      eye and the retina can, in this way, act as an accessible part of the brain.

      The investigators will detect retinal signals as electrical messages. Sensors placed near the
      eye pick up the electrical changes in the retina each time a light flashes. This
      non-invasive, routine clinical test is called an electroretinogram, (ERG). The investigators
      have carried out a study that showed differences in the ERGs recorded from adults with ASD
      compared to control participants.

      The main aim of this project is find out how common ERG differences are in children with ASD
      compared to controls. If it is common, investigators could use the ERG to make an earlier
      diagnosis of ASD and help families sooner. It could help investigators better understand the
      way the ASD brain signals and give investigators a way of measuring if therapies work.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>light adapted electroretinogram</measure>
    <time_frame>12 months</time_frame>
    <description>incidence of reduced light adapted electroretinogram in children with a diagnosis of autism spectrum disorder</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>autistic spectrum disorder</arm_group_label>
    <description>intelligence quotient IQ&gt;85 age 4-25yrs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>age 4-25yrs no eye disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>electroretinogram (ERG)</intervention_name>
    <description>an ERG is a measure of the eyes response to a flash of light</description>
    <arm_group_label>autistic spectrum disorder</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        individuals diagnosed with ASD and typically developing controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cohort 1: individuals with diagnosis ASD with an IQ measure exceeding 85

          -  cohort 2: typically developed controls without diagnosis of ASD

        Exclusion Criteria:

          -  a history of eye disease or treatment or seizure medicines that may alter retinal
             function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy A Thompson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant Clinical Scientist Visual Electrophysiology, Great Ormond Street Hospital for Children London UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Constable, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Head Of Teaching Optometry, Flinders Vision Autism Centre, Flinders University, Australia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James McPartland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor of Child Psychiatry and Psychology, Director, Yale Developmental Disabilities Clinic, Yale University, USA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James McPartland, PhD</last_name>
      <email>james.mcpartland@yale.edu</email>
    </contact>
    <investigator>
      <last_name>James McPartland, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders University</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Constable, PhD</last_name>
      <email>paul.constable@flinders.edu.au</email>
    </contact>
    <investigator>
      <last_name>Paul Constable, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swinburne University of Technology</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steve J Quinn, PhD</last_name>
      <email>sjquinn@swin.edu.au</email>
    </contact>
    <investigator>
      <last_name>Steve Quinn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital for Children NHS Trust</name>
      <address>
        <city>London</city>
        <zip>WC1N 3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dorothy A Thompson, PhD</last_name>
      <phone>0207 405 9200</phone>
      <phone_ext>0514</phone_ext>
      <email>dorothy.thompson@gosh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Irene Lee, MSc</last_name>
      <phone>0207905 2311</phone>
      <email>irene.lee@ucl.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>David H Skuse, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jane Sowden, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Lyons, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene Lee, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorothy Thompson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2018</study_first_submitted>
  <study_first_submitted_qc>February 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2018</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>electroretinogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

